SUPN - Supernus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue408,897302,238215,003147,465
Cost of Revenue15,35615,21511,9868,423
Gross Profit393,541287,023203,017139,042
Operating Expenses
Research Development89,20949,57742,79129,135
Selling General and Administrative159,888137,905106,01089,063
Non Recurring----
Others----
Total Operating Expenses264,453202,697160,787126,621
Operating Income or Loss144,44499,54154,21620,844
Income from Continuing Operations
Total Other Income/Expenses Net-4,2681,077-3,847-6,234
Earnings Before Interest and Taxes144,44499,54154,21620,844
Interest Expense-18,111-1,568-5,091-4,770
Income Before Tax140,176100,61850,36914,610
Income Tax Expense29,18343,334-40,852666
Minority Interest----
Net Income From Continuing Ops110,99357,28491,22113,944
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income110,99357,28491,22113,944
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares110,99357,28491,22113,944